Skip to content
3D Printing Certification

Biogelx commences global system launching 3D bioprinting substance in Brazil

certification

Biogelx, a Scottish biomaterial developer, has released an worldwide distribution tactic for its 3D printable inks. Working with 3D Biotechnology Remedies (3DBS), a startup specializing in tailor made bioprinter and electrospinning machines, the firm has established its sights on the Brazilian professional medical sector.

According to Sandy Bulloch, Director of Strategic Alliances at Biogelx, this new partnership will be leveraged to aid scale the organization and “provide a complete bioprinting system for numerous cell culture applications.”

“This collaboration,” Bulloch adds, “will speed up the rate of our bioprinting innovation to make the following technology of 3D tissue styles.”

Biogelx 3D printable hydrogels

Spun out of Scotland’s University of Strathclyde in 2013, Biogelx is a expert producer of synthetic hydrogels used to make 3D cell scaffolds. The company’s core technologies is the BiogelxTM self-assembling peptide hydrogel – a variety of components specifically formulated to support the expansion and proliferation of distinct mobile traces. The line was formulated by the enterprise as a viable choice to animal-derived matrices these as collagen and Matrigel. Increasing on this array before in 2019, Biogelx now also gives a vary of components appropriate for 3D bioprinting. This solution line is termed Biogelx™-INKs.

Biogelx™-INKs are now available in three distinctive formulations from the corporation – a single a conventional hydrogel, and two functionalized either by fibronectin (a big element of the extracellular matrix and blood plasma) or collagen (the structural protein of skin and connective tissues).

Syringe containing Biogelx™-INK. Photo via Biogelx
Syringe containing Biogelx™-INK. Photo through Biogelx

An intercontinental contribution to regenerative medicine 

Doing work in the industry of tissue engineering, 3DBS creates a variety of tailor made-created 3D bioprinters for use in a laboratory setting. The firm was established in 2017, nonetheless presently provides 6 solutions in its 3D bioprinter line. One particular standard design is the Genesis I technique, which enables the impartial handle of two syringe-extruders at temperatures between 25-220 °C. 

The eyesight of 3DBS, in accordance to co-founder Pedro Massaguer, “is to be a important contributor in the development of  the long run of regenerative medicine.” By partnering with Biogelx, 3DBS provides the vary of Biogelx™-INKs components to its distribution in Brazil, presenting consumers a a lot more complete deal for conducting biological investigation.

“By enabling shoppers to do the job with Biogelx™-INKs making use of our bioprinters these kinds of as Genesis™, Reactor™ or Octopus™, we are obtaining one particular stage nearer to our revolutionary aim,” Massaguer provides.

“Together, we have the prospect to supply more tissue-specific like constructs for programs in regenerative medication and drug discovery.”

The Genesis I 3D bioprinter from 3D Biotechnology Solutions. Photo via 3D Biotechnology Solutions
The Genesis I 3D bioprinter from 3D Biotechnology Alternatives. Photo through 3D Biotechnology Methods

For extra of the most recent healthcare and content updates subscribe to the 3D Printing certification Marketplace e-newsletter, comply with us on Twitter and like us on Facebook. In search of jobs in engineering? Make your profile on 3D Printing certification Jobs, or advertise to discover experts in your location.

Showcased picture shows a sample of 3D printed Biogelx™-INK. Photo by way of Biogelx